Medical Affairs is now the most vital part of the pharma organization, the brain that communicates information and knowledge to every other area. Skill in using digital technology to capture, analyze and communicate insights with authenticity is now the most critical success factor. We must use RWE, engage stakeholders, build real partnerships, orchestrate evidence generation and be the champion for patient value.
At the 13th annual eyeforpharma Japan Conference, pharma decision-makers will draw new blueprints for sustained success. It’s the only event that brings together Medical Affairs & RWE executives to learn, network and foster new collaborations. Join this event to breathe new life into your approach.
Prove the authenticity of your medicine and care provision: Ensure all communication from medical affairs is supported by real-world evidence
Strategic communication: Help the organization to understand and make decisions based on high-quality, evidence-based, contextual information
Be the patient champion: Recognize and communicate insights both internally and externally from consistent, genuine patient engagement
Digitize medical affairs: Build an agile, flexible organization to deliver for the right customer with the right product at the right time
Jovelle L. Fernandez, MD, PhD, FPOGS, Head, Japan Medical Office, Takeda Pharmaceutical Companyeyeforpharma Japan is a useful platform to be informed about recent trends in pharma industry.
4 business-critical conference streams
eyeforpharma Japan will cover all key topics with four tracks: Keynote, Digital Clinical Innovation, RWE & Medical and Commercial Excellence.
Network with attendees with 15+ hours of dedicated networking time, networking events and interactive sessions.
The most senior-level pharma event in Japan
You won’t find a better place to meet your peers since over 80% of the pharma attendees are director-level or above.
Keynote Get out of your comfort zone and explore the new frontiers of medicine from the ‘digital twin’ to advanced genomics, digital therapeutics, AI and more.
Commercial Excellence A new commercial model is needed to effectively deliver digital transformation. Use technology to provide deeper value to physicians and even patients.
RWE & Medical: Make trust your most important principle by communicating in an authentic, scientific way, backed by evidence. Use RWE to speed development, widen access and boost patient outcomes.
Digital Clinical Innovation: Cut time and cost through new technology, whilst enabling a more patient-centric approach which boosts recruitment and retention. Recognize that smarter clinical trials could unlock a golden era for pharma.
Total interaction Roundtables, workshops and panel discussions
Other events say they attract senior executives - people with clout, budget, ideas and a mission. We really mean it.
77% of attendees are director-level and above
eyeforpharma Japan attracts a variety of job titles, geographies, cultures and opinions create a rich tapestry.
Join one of the 30+ discussions taking place on topics including digital marketing, commercial excellence, patient-centricity, market access, RWE and medical affairs.
Hear from healthcare innovators on the new technologies, ideas and science that is set to disrupt the very nature of healthcare and biopharma.
Grab a coffee and a pastry and recharge your batteries, and your phones!
Find out how digital clinical trials are disrupting clinical development and creating truly patient-centric trials.
Satoru Noguchi, Ex-executive Pharma and Principal, GlobalMindsetAs times change, eyeforpharma always captures the current and future trends to help us grow our business.
Haider Alleg, Global Head of Digital Excellence / GMO, Ferring International Centereyeforpharma is a thriving community of experts exchanging opinions and finding answers. You will meet peers who understand and will help to propel your ideas forward.
Yasuyuki Katayama, Corporate Officer, Country Medical Director and Head of Medical Japan, Pfizer Japan Inc.eyeforpharma is where leaders gather and find direction, opportunities and partnerships.
Katsunori Ohyama, Director, Severe asthma dedicated sales force, GlaxoSmithKline K.K.eyeforpharma is always at the forefront of the pharma industry’s next movement.
Get in touch with the eyeforpharma team
Paul Simms Chairman
Blair Gottscho VP Operations
Kana Chia Head of Japan
Hiromasa Araki Business Development Executive, Japan
Itsumi Nishikawa Project Director
Akari Ueda Project Director, Japan
Ross McMullan Business Development Director